Synergistic Analyte Monitoring System

A novel, integrated system for continuous analyte monitoring that combines microneedle array-based sensing with AI, IoT, and blockchain technologies to provide real-time, secure, and accurate monitoring and analysis.

The original patent addressed the need for accurate and continuous analyte monitoring, particularly for diabetes management. However, it did not fully leverage advancements in AI, IoT, and blockchain to enhance the monitoring experience. This new inventive concept builds upon the original patent by integrating these distinct technologies to provide a more comprehensive and reliable system.

The Synergistic Analyte Monitoring System comprises a microneedle array-based analyte monitoring device, an AI-powered data analysis module, an IoT-enabled sensor module, and a blockchain-based data storage module. The AI-powered data analysis module analyzes sensor data from the microneedle array-based analyte monitoring device and generates alerts based on detected anomalies. The IoT-enabled sensor module monitors device performance and transmits sensor data to the cloud-based server. The blockchain-based data storage module ensures secure and tamper-proof data storage. The system can be integrated into wearable devices, mobile applications, or cloud-based servers to provide real-time analyte monitoring and alerts.

The new claims introduce a synergistic combination of microneedle array-based sensing with AI, IoT, and blockchain technologies, which provides a novel and non-obvious solution for continuous analyte monitoring. The integration of these technologies enables real-time, secure, and accurate monitoring and analysis, which is not achievable with the original patent alone.

Alternative embodiments of the Synergistic Analyte Monitoring System could include variations in the AI-powered data analysis module, such as using machine learning algorithms or deep learning models. The system could also be integrated with other technologies, such as nanotechnology or advanced materials, to enhance its performance and accuracy.

The Synergistic Analyte Monitoring System has significant commercial potential in the healthcare industry, particularly in the management of chronic diseases such as diabetes. The system's ability to provide real-time, secure, and accurate monitoring and analysis makes it an attractive solution for healthcare providers, patients, and insurance companies. The market for continuous glucose monitoring devices is expected to grow significantly in the coming years, and the Synergistic Analyte Monitoring System is well-positioned to capture a significant share of this market.